☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
uveitis
Bausch + Lomb and Clearside's Xipere Receive the US FDA's Approval for the Treatment of Macular Edema Associated with Uveitis
October 25, 2021
Bausch Health In-Licenses Clearside's Xipere (triamcinolone acetonide suprachoroidal injectable suspension) For Macular Edema Asso...
October 24, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.